Stephen H. Tsang, MD, PhD: MCO-010 for Stargardt Disease in STARLIGHT Trial
In a presentation at AAO 2023, Tsang discussed topline data from the phase 2 trial on MCO-010 optogenetic therapy for vision loss in Stargardt Disease.
Source: hcplive.com
Stephenh Tsang News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Stephenh Tsang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Stephenh Tsang Today - Breaking & Trending Today
Nanoscope Therapeutics Announces Five New Clinical and Scientific Advisory Board Appointments
/PRNewswire/ -- Nanoscope Therapeutics Inc, a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced...
Source: prnewswire.com